Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium

A study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects

Condition:
– Hypoparathyroidism
– Hypercalcemia
– Kidney Failure, Chronic

Official Title

A Phase IV, Single-Center, Active-Controlled Cross-Over Pilot Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium

Conditions

– Hypoparathyroidism- Hypercalcemia- Kidney Failure, Chronic

Study Type

Observational

Study Design

Natural History

Further Details

Study Start

Eligibility & Criteria

Ages Eligible for Study: 20 Years and above, Genders Eligible for Study: Both Criteria Subject with end stage renal disease on maintenance hemodialysis three times a week for at least 2 months prior to screening

Total Enrolment

Contact Details

[1] Creighton University, Omaha, Nebraska, 68131, United States